conventional spectrometry platforms face limitations like low throughput, high cost of ownership and complex workflows. This has fuelled the development of novel compact and easy-to-use spectrometry platforms that offer superior performance for routine analysis.

Growing Demand from Healthcare and Biopharma Industries

The healthcare and biopharma industries have always been at the forefront of adopting new technologies for improving diagnosis, monitoring disease progression and developing new drugs. Mass spectrometry based methods have become indispensable tools in proteomics, metabolomics and other ‘omics’ applications that drive modern drug discovery and precision medicine efforts. However, traditional spectrometry platforms are complex, big-sized systems requiring specialized technicians to operate. This limits their widespread adoption, especially in clinical settings and resource-constrained labs.

Novel compact platforms that are fully-automated and plug-and-play have gained significant traction as they address key limitations of conventional systems. Their small footprint and user-friendly design enables positioning them on every laboratory bench and even deployment at point-of-care settings. Advanced software and automated workflows further simplify mass spec analysis for non-expert users. Rising focus on personalized healthcare and companion diagnostics has also driven demand for compact systems that can perform high-quality analysis with minimum operator intervention.

‣ Novel Spectrometry Platforms Set: https://www.coherentmi.com/blog/novel-spectrometry-platforms-set-for-rapid-growth-with-increasing-adoption-in-healthcare-and-biopharma-industries-118